The clinical effectiveness of immunotherapy with the cell wall skeleton of Bacillus Calmette-Guérin was assessed in a study involving 140 consecutive patients with gastric cancer, who were gastrectomized at a single institution from January 1976 through December 1978. These patients were randomized by an envelope method after operation and divided into three treatment groups: ‘control’, ‘chemotherapy’, and ‘chemotherapy plus immunotherapy with BCG-CWS.’ Only two patients who died during surgery were excluded, and a survey of survival periods was made on the remaining 138 patients in January 1982.
As a result, statistically significant differences in the survival rate curve were observed between the control and chemotherapy plus immunotherapy groups (P<0.01), and between the chemotherapy and chemotherapy plus immunotherapy groups (P<0.05). These results emphasize effectiveness of BCG-CWS as an adjuvant immunotherapeutic agent in gastrectomized cancer patients.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Aungst CW, Sokal JE, Jager BV (1975) Complications of BCG vaccination in neoplastic disease. Ann Intern Med 82:666
Bast RC Jr, Zbar B, Borsos T, Rapp HJ (1974) BCG and cancer. (Part I of II) N Engl J Med 290:1413
Eilber FR, Morton DL, Holmes EC, Sparks FC, Ramming KP (1976) Adjuvant immunotherapy with BCG in treatment of regional lymph node metastases from malignant melanoma. N Engl J Med 294:237
Falk RE, MacGregor AB, Landi S, Ambus U, Langer B (1976) Immunostimulation with intraperitoneally administered Bacille Calmette Guérin for advanced malignant tumors of the gastrointestinal tract. Surg Gynecol Obstet 142:363
Gehan EA (1965) A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrika 52:203
Gutterman JU, Hersh EM, Rodriguez V, McCredie KB, Mavligit G, Reed R, Burgess MR, Smith T, Gehan E, Bodey Sr GP, Freireich EJ (1974) Chemoimmunotherapy of adult acute leukemia. Prolongation of remission in myeloblastic leukemia with BCG. Lancet II:1405
Japanese Research Society for Gastric Cancer (1981) The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 11:127
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457
Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schlumberger JR, Hayat M, de Vassal F (1969) Active immunotherapy for acute lymphoblastic leukemia. Lancet I:697
Nakayama K (1968) Surgery of the stomach and duodenum. In: Atlas of gastrointestinal surgery. Igaku Shoin, Tokyo, p 235
Sparks FC, Ramming KP (1976) Immunotherapy of gastrointestinal cancer: The potential. Clin Gastroenterol 5:855
Stewart THM, Hollinshead AG, Harris JE, Belanger R, Crepeau A, Hoopoer GD, Sachs HJ, Klaassen DJ, Hirte W, Rapp E, Crook AF, Orizaga M, Sengar DPS, Raman S (1976) Immunochemotherapy of lung cancer. Ann NY Acad Sci 277:436
Yamamura Y, Sakatani M, Ogura T, Azuma I (1979) Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS). Cancer 43:1314
Yasumoto K, Manabe H, Ueno M, Ohta M, Ueda H, Iida A, Nomoto K, Azuma I, Yamamura Y (1976) Immunotherapy of human lung cancer with BCG cell-wall skeleton. Gan 67:787
About this article
Cite this article
Ochiai, T., Sato, H., Hayashi, R. et al. Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. Cancer Immunol Immunother 14, 167–171 (1983). https://doi.org/10.1007/BF00205355
- Treatment Group
- Cancer Patient
- Cell Wall
- Survival Rate
- Gastric Cancer